These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2888862)

  • 21. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal.
    Ongini E; Caporali MG; Massotti M
    Life Sci; 1985 Dec; 37(24):2327-33. PubMed ID: 3877855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G
    Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.
    Barone P; Davis TA; Braun AR; Chase TN
    Eur J Pharmacol; 1986 Apr; 123(1):109-14. PubMed ID: 2872071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
    Sharma A; Kulkarni SK
    Indian J Exp Biol; 1994 Mar; 32(3):176-9. PubMed ID: 8070837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
    Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
    Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M; Fenu S; Di Chiara G
    Life Sci; 1987 Jan; 40(3):245-51. PubMed ID: 2948094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade.
    Barone P; Tucci I; Parashos SA; Chase TN
    Eur J Pharmacol; 1988 May; 149(3):225-32. PubMed ID: 3261693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
    Neisewander JL; Lucki I; McGonigle P
    J Pharmacol Exp Ther; 1991 May; 257(2):850-60. PubMed ID: 2033524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors.
    Starr MS
    Eur J Pharmacol; 1988 Jul; 151(3):479-82. PubMed ID: 3265106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha 2-adrenoceptor- and D2-dopamine receptor-mediated analgesic response of B-HT 920.
    Verma A; Kulkarni SK
    J Pharm Pharmacol; 1991 Feb; 43(2):131-3. PubMed ID: 1672900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS; Starr BS
    Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analogs of SCH 23390 as discriminators of dopamine receptor subtypes: behavioral interactions between D-1 and D-2 agonists and antagonists.
    O'Boyle KM; Molloy AG; Mashurano M; Waddington JL
    Psychopharmacol Bull; 1986; 22(3):599-604. PubMed ID: 2879303
    [No Abstract]   [Full Text] [Related]  

  • 40. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
    Jackson DM; Hashizume M
    Psychopharmacology (Berl); 1986; 90(1):147-9. PubMed ID: 3094056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.